Plan I standing certainly increases the degree of complexity for almost any investigation research. As an example, all researchers—no matter if preclinical or clinical—will have to receive Routine I investigate registrations. 21 CFR section 1301.18. Against this, researchers who may have DEA Practitioner registrations in Schedules II–V (which